Dignitana AB Publishes Q2 2024 Interim Report
Advancing forward with clear vision
Financial highlights Q2 2024
- Net Sales amounted to 21.8 MSEK (21.1), an increase of 4 percent over the same quarter in 2023.
- Operating Result amounted to -11.0 MSEK (-4.7).
- Net Result after financial items amounted to -11.5 MSEK (-4.7).
- EBITDA for the second quarter were negative at -7.0 MSEK (-0.9).
- Earnings per share were -0.14 SEK (-0.07).
- Cash Balance amounted to 7.0 MSEK (5.4).
- Average Daily Treatment Revenue (ADTR)* was 223 TSEK (241) in the quarter.
Business highlights during the period
- Dignitana Rights Issue was fully subscribed at 19.1 MSEK before issue cost.
- In May Dignitana published the Annual Report for 2023.
- Dignitana’s Annual General Meeting was held on 23 May 2024, electing Fredrik Lindgren and Dr. Hope Rugo as new Directors.
- Fredrik Jonsson was appointed as CEO beginning 1 May 2024 following the resignation of Catarina Löwenadler.
- Dignitana Board Member William Cronin resigned.
Business highlights after the period
- Dignitana signed a multi-year Distribution Agreement for Konica Minolta to be the exclusive provider of The DigniCap Scalp Cooling System in Japan.
- Dignitana participated in the Annual Congress of the Oncology Nursing Society in Washington, D.C.
Key Figures
| DIGNITANA GROUP | Q2 2024 | Q2 2023 | Q1-Q2 2024 | Q1-Q2 2023 | Full Year 2023 |
| Net sales, TSEK | 21,844 | 21,089 | 43,009 | 42,578 | 86,063 |
| Total revenues, TSEK | 22,046 | 23,159 | 43,334 | 44,764 | 89,025 |
| Net profit after financial items, TSEK | -11,454 | -4,662 | -16,510 | -8,600 | -17,228 |
| Cash and bank balances, TSEK | 6,977 | 5,423 | 6,977 | 5,423 | 6,027 |
| Earnings per share before and after dilution, SEK | -0.14 | -0.07 | -0.22 | -0.12 | -0.25 |
| Average Daily Treatment revenue*, TSEK | 223 | 241 | 232 | 242 | 239 |
*ADTR includes pay-per-treatment revenue from patients and facilities in the U.S. Does not include lease revenue or disposable sales.
All financial reports are available at www.dignitana.com/investor-relations/financial-reports/
This disclosure contains information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 22-08-2024 08:00 CET.
